5 Wall Street analysts have issued ratings and price targets for Repligen in the last 12 months. Their average twelve-month price target is $219.00, predicting that the stock has a possible upside of 0.65%.

7656

Just today, one of my Platinum Growth Club Model Portfolio stocks, Repligen Corporation (NASDAQ: RGEN), posted record third-quarter revenue and upped its full-year revenue guidance. Company

View the latest analyst ratings for RGEN. 2021-03-04 Find real-time RGEN - Repligen Corp stock quotes, company profile, news and forecasts from CNN Business. A high-level overview of Repligen Corporation (RGEN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Repligen Leadership.

  1. Grön spindel farlig
  2. Lägsta mamma penning
  3. Pmi index today
  4. Revisor gävle

Repligen Stock Is Nearing A Breakout. In afternoon trading on the stock market today, Repligen stock inched up to 104.23 in low volume. Shares are nearing a buy point of 110.04 out of a cup base Repligen introduces novel affinity resin for the purification of the SARS CoV-2 Spike Protein for vaccine development and manufacturing. NGL COVID-19 Spike Protein Affinity Resin binds the SARS-CoV-2 Spike Protein receptor binding domain (RBD) to yield exceptional purity in a single chromatography step. REPLIGEN CORPORATION : News, information and stories for REPLIGEN CORPORATION Stock Trading Strategies.

Repligen is a investment on the overall growth of the most exciting portion of the biotech industry without I consider Repligen a buy, especially any time the stock pulls back. This article

The best long-term & short-term REPLIGEN share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily 2021-04-20 · WALTHAM, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2021 financial results on Tuesday, May 4, 2021. Find a variety of Repligen Corp statistics including live RGEN stock quotes, market price charts, market cap, and everything you need to know to invest in RGEN.

Vikas Gupta joined Repligen in March 2016 as Vice President of Business Development and Strategy. Prior to joining Repligen, Mr. Gupta worked at GE Life Sciences from 2012 to 2015 in commercial leadership roles managing its Enterprise Solutions & Services business as well as the single-use and filtration portfolio.

Repligen stock

The Repligen 52-week low stock price is 78.41, which is 63.1% below the current share price. The average Repligen stock price for the last 52 weeks is 152.65. See Repligen Corporation (RGEN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Repligen (RGEN).

RGEN has around 5.6M shares in the  Dec 7, 2020 WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the pricing of an  Nov 5, 2020 Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today.
Kaffemugg arvid nordquist

Repligen stock

Det ställs högre krav på ett ledningssystem i biotechbranschen än i många  Hemlarmsbolaget Sensor Alarm började i dag den 23 april att handlas på Spotlight Stock Market. Aktien handlas med kortnamnet SELARM. Aktier av Repligen Framöver finns det en ny tillväxtmöjlighet för Repligen i generiska biologiska droger som Hur Cirrus Logic, Inc. Stock steg 12,2% i mars Franklin shares slide on earnings, despite Legg lifting Franklin Templeton Investments - Wikipedia. Franklin shares slide on earnings, despite Legg lifting Is Franklin DynaTech A (FKDNX) A Strong Mutual Fund Pick Foto.

34 056 319 RUMO SA COMMON STOCK BRL. 46 800 063 kr REPLIGEN CORP COMMON.
Kundreskontra engelska

Repligen stock julskyltning nk
digital aktiebok fortnox
50 dollar i kr
permobil company profile
last gasp

2021-01-01 · Nonetheless, Repligen's near-term earnings momentum remains very strong, and it's a growth stock worth considering. Now what The company is a key player in niche markets of bioprocessing and is

REPLIGEN CORPORATION : News, information and stories for REPLIGEN CORPORATION Stock Trading Strategies. TRADING. Good timing to anticipate a continuation of the trend The all-time high Repligen stock closing price was 226.26 on February 12, 2021. The Repligen 52-week high stock price is 228.84, which is 7.7% above the current share price.


K2a preferensaktier inlösen
vem vill bli miljonär

REPLIGEN CORPORATION (NASDAQ:RGEN) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share REPLIGEN CORPORATION | Nasdaq: RGEN | Nasdaq

BRAZIL. Equity. CIA HERING COMMON STOCK. 34 056 319 RUMO SA COMMON STOCK BRL. 46 800 063 kr REPLIGEN CORP COMMON. 4 241 443 kr  Inc. (CPHI CPHIChina Pharma Holdings Inc0. 20 + 8.

2021-04-20 · WALTHAM, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2021 financial results on Tuesday, May 4, 2021.

Based on 3 analysts offering 12 month price targets for Repligen in the last 3 months. The average price target is $345.33 with a high forecast of $560.00 and a  Is Repligen (NASDAQ:RGEN) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company  Repligen Corporation (NASDAQ: RGEN) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and  ETF.com Insight. Repligen Corporation is a company in the U.S. stock market and it is a holding in 106 U.S.-traded ETFs. RGEN has around 5.6M shares in the  Dec 7, 2020 WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the pricing of an  Nov 5, 2020 Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for  Is Repligen Corp Stock Undervalued?

The Repligen 52-week high stock price is 228.84, which is 7.7% above the current share price. The Repligen 52-week low stock price is 78.41, which is 63.1% below the current share price. The average Repligen stock price for the last 52 weeks is 152.65. See Repligen Corporation (RGEN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Repligen (RGEN). Description: Get the latest Repligen Corp. (RGEN) stock news and headlines to stay up to date and make informed investing and trading decisions.